￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the latest developments in whether Eslicarbazepine has been included in medical insurance and reimbursement policies

2026-02-01 22:25:32

Check Details
Standard dosage and usage of Anagrelide and dose adjustment plans for different patients

2026-02-01 22:25:32

Check Details
Analysis of medication safety matters that need to be paid attention to while taking apalutamide (Ansenko)

2026-02-01 22:25:32

Check Details
What is the clinical efficacy of elacestrant? Real patient treatment feedback and effect evaluation

2026-02-01 22:25:32

Check Details
Dosage specifications of F/TAF and suggestions for adjusting the dosage according to different situations

2026-02-01 22:25:32

Check Details
Drug safety analysis and long-term use risk assessment of Pimitespib

2026-02-01 22:25:32

Check Details
Afatinib (Gitairin) side effects appear time and treatment suggestions

2026-02-01 22:25:32

Check Details
Description of the standard dosage and individualized adjustment plan of DaliRasheng (Keweike)

2026-02-01 22:25:32

Check Details
Whether olaparib (lipadro) needs to be taken for life and long-term safety assessment

2026-02-01 22:25:32

Check Details
Long-term maintenance treatment with venetoclax/venetoclax (venetoclax) can last for several years and is safe

2026-02-01 22:25:32

Check Details
Latest information on drug storage and price adjustment for Asnib/Assiminib (Sinbel)

2026-02-01 22:25:32

Check Details
Real evaluation and clinical data analysis of the therapeutic effect of ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Category
相关知识